NEOPLASM METASTASIS

Clinical trials for NEOPLASM METASTASIS explained in plain language.

Never miss a new study

Get alerted when new NEOPLASM METASTASIS trials appear

Sign up with your email to follow new studies for NEOPLASM METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 7 Completed 10 Terminated 1

New drug switch strategy aims to outsmart tough breast cancer

Disease control Not yet recruiting

This study tests if switching between two different targeted drugs (sacituzumab govitecan and trastuzumab deruxtecan) can help people with a hard-to-treat, advanced breast cancer called HER2-low triple-negative breast cancer live longer. About 260 adults with metastatic or locall…

Matched conditions: NEOPLASM METASTASIS

Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

NEOPLASM METASTASIS

Get alerted when new NEOPLASM METASTASIS trials appear

New drug switch strategy aims to outsmart tough breast cancer